Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kura Oncology

7.63
-0.0250-0.33%
Volume:773.35K
Turnover:5.87M
Market Cap:661.83M
PE:-3.38
High:7.76
Open:7.69
Low:7.48
Close:7.65
52wk High:21.57
52wk Low:5.41
Shares:86.80M
Float Shares:63.99M
Volume Ratio:0.45
T/O Rate:1.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2592
EPS(LYR):-2.0193
ROE:-51.11%
ROA:-22.93%
PB:2.17
PE(LYR):-3.78

Loading ...

Sector Update: Health Care Stocks Climb Late Afternoon

MT Newswires Live
·
Aug 16

Kura Oncology Shares Rise After CEO Buys Company Shares

MT Newswires Live
·
Aug 16

Kura Oncology Up Over 13%, on Pace for Largest Percent Increase Since January 2024 -- Data Talk

Dow Jones
·
Aug 15

Stock Track | Kura Oncology Soars 5.45% as CEO Makes Significant Stock Purchase

Stock Track
·
Aug 15

Kura Oncology’s CEO Makes a Bold Move with Significant Stock Purchase

TIPRANKS
·
Aug 15

Troy E. Wilson, President and CEO of Kura Oncology Inc., Reports Acquisition of Common Shares

Reuters
·
Aug 15

Kura Oncology price target lowered to $27 from $29 at BofA

TIPRANKS
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Globus Medical (GMED) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 11

Stock Track | Kura Oncology Plummets 5.70% Pre-Market on Disappointing Q2 Earnings

Stock Track
·
Aug 08

Stock Track | Kura Oncology Plummets 5.70% in Pre-Market Following Disappointing Q2 Earnings Report

Stock Track
·
Aug 08

BTIG Reaffirms Their Hold Rating on Kura Oncology (KURA)

TIPRANKS
·
Aug 08

Kura Oncology’s Promising Future: Strong Financials and Advancements in AML Treatment Drive Buy Rating

TIPRANKS
·
Aug 08

Kura Oncology Advances Cancer Drug Pipeline with FDA Review

TIPRANKS
·
Aug 08

Kura Oncology: Strong Financials and Promising Clinical Developments Drive Buy Rating

TIPRANKS
·
Aug 08

Kura Oncology’s Promising Clinical Developments and Financial Stability Justify Buy Rating

TIPRANKS
·
Aug 08

Kura Oncology Q2 EPS $(0.75) Misses $(0.43) Estimate, Sales $15.288M Miss $36.664M Estimate

Benzinga
·
Aug 08

Kura Oncology Q2 EPS USD -0.75

THOMSON REUTERS
·
Aug 08

Kura Oncology Reports Second Quarter 2025 Financial Results

GlobeNewswire
·
Aug 08

BRIEF-Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule

Reuters
·
Aug 04

Kura Oncology reports inducement grants under Nasdaq listing rule

TIPRANKS
·
Aug 04